UnitedHealth Group posted second-quarter adjusted earnings that beat analysts’ forecasts and the company raised its earnings outlook for the full year.
“This provides concrete evidence that the [managed care organizations] will likely report 2Q earnings beats largely across the board, given a benign medical cost environment,” wrote Stephens analyst Scott Fidel on Friday.
Fidel reiterated his Overweight rating on the stock and $580 price target.
“The group commands significant commercial market pricing power to manage margins during periods of rising overall inflation,” Fidel wrote.
Stephens Private Wealth Management Hires Nashville Financial Consultant Ryan Cernoch as Vice President